Svas Biosana SpA
MIL:SVS
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Svas Biosana SpA
Total Equity
Svas Biosana SpA
Total Equity Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Total Equity | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
S
|
Svas Biosana SpA
MIL:SVS
|
Total Equity
€62.8m
|
CAGR 3-Years
7%
|
CAGR 5-Years
22%
|
CAGR 10-Years
N/A
|
|
|
I
|
Ivision Tech SpA
MIL:IVN
|
Total Equity
€9.8m
|
CAGR 3-Years
44%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Svas Biosana SpA
Glance View
Svas Biosana SpA distributes medical appliances. The company is headquartered in Somma Vesuviana, Napoli and currently employs 367 full-time employees. The company went IPO on 2021-12-09. The firm consists of four divisions namely: Farmex division, manufactures range of gauze and cotton made products; Medical division, provides suction line, infusion line, and custom packs; Svas division, provides own brand products, specialities, galenic solutions and disposables; and Harvest division, provides electromedical equipments, after-sales technical services. The firm is the subsidiary of Svas group. Test Data.
See Also
What is Svas Biosana SpA's Total Equity?
Total Equity
62.8m
EUR
Based on the financial report for Dec 31, 2024, Svas Biosana SpA's Total Equity amounts to 62.8m EUR.
What is Svas Biosana SpA's Total Equity growth rate?
Total Equity CAGR 5Y
22%
Over the last year, the Total Equity growth was 7%. The average annual Total Equity growth rates for Svas Biosana SpA have been 7% over the past three years , 22% over the past five years .